AGTR2 and diabetes mellitus: A significant proportion of patients with DM were more likely to be on angiotensin‐converting enzyme (ACE) inhibitors [23.4% vs. 9.0%, OR, 95% CI 3.1 (1.3–7.4), p = .0086] and angiotensin 2 receptor blockers (ARBs) [40.6% vs. 17.1%, OR, 95% CI 3.3 (1.6–6.7), p = .0006].